{"relation": [["", "STARTED", "COMPLETED", "NOT COMPLETED", "Economic reasons", "Death"], ["Lopinavir/Ritonavir Group", "98", "92", "6", "1", "5"]], "pageTitle": "Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China - Study Results - ClinicalTrials.gov", "title": "", "url": "https://clinicaltrials.gov/ct2/show/results/NCT01074931?sect=X4015&view=results", "hasHeader": true, "headerPosition": "FIRST_ROW", "tableType": "RELATION", "tableNum": 4, "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042989443.69/warc/CC-MAIN-20150728002309-00339-ip-10-236-191-2.ec2.internal.warc.gz", "recordEndOffset": 877693107, "recordOffset": 877677078, "tableOrientation": "HORIZONTAL", "textBeforeTable": "Participant Flow: \u00a0 Overall Study Adult participants with HIV-1 infection taking lopinavir/ritonavir Lopinavir/Ritonavir Group Description \u00a0 Reporting Groups No text entered. Significant events and approaches for the overall study following participant enrollment, but prior to group assignment Pre-Assignment Details No text entered. Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations Recruitment Details \u00a0 Hide Participant Flow \u00a0 Participant Flow Drug: Lopinavir/ritonavir (Kaletra) Intervention: HIV-1 Infections Condition: Time\u00a0Perspective:\u00a0Prospective Study Design: Observational", "textAfterTable": "\u00a0 Baseline Characteristics \u00a0 Hide Baseline Characteristics Population Description Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate. No text entered. Reporting Groups \u00a0 Description Lopinavir/Ritonavir Group Adult participants with HIV-1 infection taking lopinavir/ritonavir Baseline Measures \u00a0 \u00a0 Lopinavir/Ritonavir Group \u00a0 Number of Participants \u00a0 [units:\u00a0participants] \u00a0 98 \u00a0 Age \u00a0 [units:\u00a0years] Mean (Standard Deviation) \u00a0 39.86 \u00a0(10.41) \u00a0 Gender \u00a0", "hasKeyColumn": true, "keyColumnIndex": 0, "headerRowIndex": 0}